MAY 26, 2020 5:34 PM PDT

Alzheimer's Gene Doubles Risk of Severe COVID-19

WRITTEN BY: Annie Lennon

Researchers from the University of Exeter, England, and the University of Connecticut have found that people carrying faulty gene APOE e4e4 are more likely to have severe symptoms from COVID-19 than those with a different variant. 

The gene has previously been linked to Alzheimer's disease in Caucasian people. Having two faulty copies of the gene, common to 1 in 36 people of European descent, has been known to increase one's risk of Alzheimer's by 15 times, as well as increase one's risk of heart disease. 

For their study, the researchers analyzed data from the UK Biobank study, a collection of health and genetic data of 500,000 people. They found that while most people in the population had not been exposed to the virus, 2.36% of those with European ancestry had the APOE e4e4 gene, whereas 5.13% of those tested positive for COVID-19 had this gene variant. Meanwhile, those with the e3e3 variant of the same gene were less than half as likely to test positive for the virus. 

The researchers concluded that the APOE e4e4 gene's presence might increase one's chances of developing severe COVID-19 symptoms. These results match their previous findings showing that people with dementia are three times as likely than those without to get severe COVID-19 symptoms. 

"This is an exciting result because we might now be able to pinpoint how this faulty gene causes vulnerability to COVID-19. This could lead to new ideas for treatments. It's also important because it shows again that increasing disease risks that appear inevitable with aging might actually be due to specific biological differences, which could help us understand why some people stay active to age 100 and beyond, while others become disabled and die in their sixties." says co-author of the study, Dr. Chia-Ling Kuo. 

Professor David Melzer, lead author if the study, says, "Several studies have now shown that people with dementia are at high risk of developing severe COVID-19. This study suggests that this high risk may not simply be due to the effects of dementia, advancing age or frailty, or exposure to the virus in care homes."


 

Sources: Neuroscience News, Medscape, The Scientist, The Journals of Gerontology 

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
APR 23, 2020
Cannabis Sciences
APR 23, 2020
No Difference Between Indica and Sativa Cannabis Strains
Cannabis growers and sellers have defined different strains of cannabis as ‘indica’ or ‘sativa’ ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
FDA Fast Tracks Vaccine for COVID-19
Biopharmaceutical company, Moderna, has announced that the US Food and Drug Administration has approved its experimental ...
MAY 19, 2020
Neuroscience
MAY 19, 2020
Researchers Find Brain Cells that Shut Down Pain
Researchers at Duke University have found that a small group of cells in the brain may be able to regulate our sense of ...
JUN 18, 2020
Neuroscience
JUN 18, 2020
Living Environment Correlated with Living to 100
Researchers from Washington State University have found that where you live may predict how long you will live. In a stu ...
JUN 22, 2020
Drug Discovery & Development
JUN 22, 2020
MDMA Has Long-Term Benefits Against PTSD
Researchers have shown that MDMA-assisted psychotherapy has therapeutic effects that last over a year in treating post-t ...
JUL 02, 2020
Drug Discovery & Development
JUL 02, 2020
Common Asthma Drug Could Treat Alzheimer's
Researchers from Lancaster University, England, have found that Salbutamol, a medication commonly used to treat asthma, ...
Loading Comments...